Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary: The limited role of vaccines in the prevention of acute gastroenteritis.

MSMR·2020
Same author

H63D variant of the homeostatic iron regulator (HFE) gene alters α-synuclein expression, aggregation, and toxicity.

Journal of neurochemistry·2020
Same author

Editorial: Mitigating the risk of disease from tick-borne encephalitis in U.S. military populations.

MSMR·2019
Same author

Evaluation of tryptase after subcutaneous immunotherapy-associated systemic reactions.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2019
Same author

Persistent Hemichorea and Caudate Atrophy in Untreated Diabetic Striatopathy: A Case Report.

Case reports in neurology·2018
Same author

Neurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos.

Environmental health perspectives·2016

Related Experiment Video

Updated: Jun 4, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Potential therapies for peanut allergy.

Mark C Stahl1, Tonya S Rans

  • 1Wilford Hall Medical Center, US Air Force, Lackland AFB, Texas, USA. mark.stahl@us.af.mil

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|March 1, 2011
PubMed
Summary

New therapies for peanut allergy are emerging, aiming for sustained oral tolerance beyond current avoidance strategies. While promising, these treatments are still developing and may require combination approaches for safety and efficacy.

More Related Videos

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Related Experiment Videos

Last Updated: Jun 4, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Area of Science:

  • Immunology
  • Allergology
  • Clinical Medicine

Background:

  • Peanut allergy affects over 1% of the US population, with increasing prevalence.
  • Current management relies on avoidance and self-injectable epinephrine, lacking definitive long-term solutions.

Purpose of the Study:

  • To review investigated therapies for peanut allergy beyond avoidance and epinephrine.
  • To assess the progress and potential of emerging peanut allergy treatments.

Main Methods:

  • A comprehensive PubMed search was conducted using keywords 'peanut allergy' and 'therapy'.
  • References from relevant articles were reviewed to identify additional pertinent studies.
  • Over 120 articles were reviewed, with selections based on subject matter relevance.

Main Results:

  • Multiple peanut allergy therapies have been researched over the past 15 years, yielding promising results.
  • The primary goal is sustained oral tolerance, though most current therapies are nascent and cannot yet demonstrate this.
  • Ideal therapeutic options should be safe, easily administered, and cost-effective, potentially requiring combined modalities to minimize risk.

Conclusions:

  • Peanut allergy presents a diagnostic challenge due to limited treatment options.
  • Emerging therapies show potential to become accepted treatments within the next decade.
  • Achieving tolerance to unintentional peanut ingestion would significantly improve quality of life for patients and families.